March 31, 2011 ·
1 comment
March 31, 2011 (CHAPEL HILL, NC)—Paul Meade, the president and founder of Thought Leader Select, a Research Triangle, NC company focused on facilitating medical expert collaborations with the biopharmaceutical and other healthcare industries, has accepted an invitation to speak at the annual meeting of the American Association of Clinical Endocrinologists (AACE).
The 20th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists will take place from April 13-17 in San Diego, CA. At the invitation of AACE President-Elect Dr. Yehuda Handelsman, Meade will speak during the annual Corporate AACE Partner (CAP) meeting, an opportunity for physicians and representatives from partnering companies, including biopharmaceutical and medical device firms, to learn about emerging topics in inter-industry collaborations in medicine.
Meade’s speech, “Interactions in the Age of Transparency,” will outline a new path forward for even better industry collaborations with medical experts based on a foundation of ethics and transparency. “I am honored to accept the invitation from Dr. Handelsman and the AACE,” stated Meade. “I have built my career on the basis of an unwavering commitment to ethics and transparency. We have to remember that we’re all in this together—health care providers, researchers, and people from industry—to promote better health for everyone in this country. If we always keep patients’ best interest in mind and work together is an open ... read more »
TAGS: 
AACE American Association of Clinical Endocrinologists Annual Meeting biopharmaceutical Clear Point Hlealth Dr. Yehuda Handelsman emerging topics ethics healthcare Interactions in the Age of Transparency medical expert Paul Meade Thought Leader Select transparency
August 2, 2010 ·
2 comments
Key opinion leaders (KOLs) are health care leaders who make a high-impact footprint while advancing medical science. Thought Leader Select specializes in delivering objective, validated data on the skills and experiences of KOLs, so that pharmaceutical companies can seek their advice and guidance in the development of new medicines.
Over the past several years, Thought Leader Select has studied physician key opinion leaders who treat diabetes and analyzed their involvement in many areas, including clinical research, treatment guidelines involvement, publishing, reimbursement involvement and participation in advocacy efforts. In a recent assessment of nearly 500 diabetes KOLs across the United States, Thought Leader Select examined their participation in patient advocacy activities. Using keywords to link these KOLs with such activities, Thought Leader Select found that 62% of physicians regularly take part in patient advocacy efforts, such as participation in advocacy organizations, patient education or legislative efforts (see Chart 1).
Of the 301 KOLs with advocacy involvement, most take part in five or fewer activities, while only 3% of them boast 10 or more advocacy activities and/or awards. In addition to activities through the American Diabetes Association (ADA) and American Association of Clinical Endocrinologists (AACE) – especially the American College of Endocrinology’s Power of Prevention (POP) program – top advocacy initiatives and organizations include:
• Taking ... read more »
TAGS: 3163 AACE ACE ADA American Association of Clinical Endocrinologists American College of Endocrinology American Diabetes Association biopharmaceutical biotechnology Centers for Medicare and Medicaid Services CMS diabetes Diabetes Action Research and Education Foundation diabetes camp Diabetes Self Management FDA Food and Drug Administration health care health coverage health legislation healthcare key opinion leaders patient advocacy patient education pharmaceutical physicians POP Power of Prevention Specter Amendment state diabetes plan Taking Control of Your Diabetes TCOYD thought leaders United States
